Literature DB >> 26708277

Quality indicators in pituitary surgery: a need for reliable and valid assessments. What should be measured?

Michael Powell1, Ashley Grossman2.   

Abstract

Engagement with improving the quality of clinical care is a key component of medical professionalism. Central to Quality Improvement (QI) agenda are the development of valid, reliable and accurate quality metrics. We cannot improve what we do not measure. Pituitary surgery, which in the 21st century usually means trans-sphenoidal surgery (TSS), is unusual; it is a neurosurgical procedure in which complex outcomes can be measured precisely. We have clear guidelines for establishing remission/cure in functional endocrine disease and precise diagnostic tools with which to investigate our patients. Visual recovery can be equally precisely measured with standardised equipment. Moreover, TSS is one of the commonest major surgical procedures carried out in the 34 UK individual neurosurgical units. Most will carry out about 30-40 procedures each year, with four or five units notably higher with numbers in excess of one hundred cases. There are, potentially, plenty of data out there. Given this background, how best should we measure quality in this important area of clinical practice?
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 26708277     DOI: 10.1111/cen.13007

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  2 in total

1.  Multidisciplinary Team Care in the Surgical Management of Pituitary Adenoma.

Authors:  Jessica W Grayson; Agnish Nayak; Mark Winder; Benjamin Jonker; Raquel Alvarado; Henry Barham; Ann McCormack; Richard J Harvey
Journal:  J Neurol Surg B Skull Base       Date:  2019-10-21

2.  Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.

Authors:  Felipe F Casanueva; Ariel L Barkan; Michael Buchfelder; Anne Klibanski; Edward R Laws; Jay S Loeffler; Shlomo Melmed; Pietro Mortini; John Wass; Andrea Giustina
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.